Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Raji Shameem"'
Publikováno v:
Journal of Cancer Epidemiology, Vol 2015 (2015)
Externí odkaz:
https://doaj.org/article/83fb894476014e919af1fedf0f035734
Publikováno v:
Acta Oncologica. 54:124-132
Inhibitors of the mammalian target of rapamycin (mTOR) are currently approved for the treatment of several cancers, and their use is associated with serious rash, which affects patient's quality of life and leads to undesirable dose reductions or int
Publikováno v:
Acta oncologica (Stockholm, Sweden). 55(9-10)
Everolimus has been used widely in cancer patients and is associated with the development of hyperglycemia. Due to confounding factors, its specific impact on hyperglycemia has not been well understood. We performed a meta-analysis of randomized cont
Publikováno v:
Anticancer research. 35(4)
Everolimus, an inhibitor of mammalian target of rapamycin (mTOR) used for the treatment of various solid tumors, is associated with anemia, which can lead to morbidity and treatment interruption or discontinuation. Because the underlying causes of an
Publikováno v:
Cancer investigation. 33(3)
Inhibitors of the mammalian target of rapamycin (mTOR) pathway including everolimus and temsirolimus have been used extensively in cancer patients. Their use is associated with stomatitis, an adverse event resulting in morbidity and treatment interru
Autor:
Kevin M. Sullivan, Khalid Gafoor, Raji Shameem, Muhammad Saad Hamid, Bushra Mina, Jason George
Publikováno v:
Journal of Cancer Epidemiology, Vol 2015 (2015)
Journal of Cancer Epidemiology
Journal of Cancer Epidemiology
Background. The objective of our study was to ascertain racial/ethnic disparities in Asian/Pacific Islanders (API) for non-small-cell lung cancer (NSCLC) clinicopathologic features and survival outcomes based on various tumor characteristics and trea
Autor:
Miriam N. Lango, Jessica Bauman, Ranee Mehra, Raji Shameem, Thomas J. Galloway, John A. Ridge, Muhammad Saad Hamid
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 94:915-916
Autor:
Patricia Kropf, Hagop M. Kantarjian, Henry C. Fung, Philip A. Pancari, Xuelin Huang, Raji Shameem, Woonbok Chung, Jean Pierre J. Issa, Lianchun Xiao
Publikováno v:
Blood. 128:3170-3170
Introduction: DAC is a hypomethylating agent FDA approved for the treatment of advanced myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML).Despite its clinical activity, the duration of response is limited and prognosis at rel
Autor:
Kevin M. Sullivan, Raji Shameem, Nakul Singhal, Avrind Randhawa, Mohammad Hamid, Niket Sonpal, David DiCaprio
Publikováno v:
American Journal of Gastroenterology. 109:S633-S634
Autor:
Raji Shameem, Jack Ansell
Publikováno v:
Best practiceresearch. Clinical haematology. 26(2)
Vitamin K antagonists have been in wide use for over 70 years. Warfarin, the most commonly used vitamin K antagonist, has been shown to be highly effective in treating and preventing thrombosis. Despite this, warfarin has many disadvantages, which ha